MedPath

a Predictive Scheme for Poor Responders in IVF Cycles

Completed
Conditions
Infertility
Interventions
Other: transvaginal Ultrasound
Registration Number
NCT02351193
Lead Sponsor
Dina Mohamed Refaat Dakhly
Brief Summary

While practicing the different assisted reproductive techniques, the investigators are faced daily by the problem of poor responder females, and the debate about predicting its results based on the outcome of the different ORTs used. Due to the cost of AMH as an indicator for ovarian response, the need to re-assess its role was essential in our community, which led us to conduct this prospective multi-center IVF study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
928
Inclusion Criteria
  • normal body mass index (BMI)
  • AMH from 0.5-1.1 ng/ml.
  • previous history of ≤3 oocytes retrieved using conventional long stimulation protocol
Exclusion Criteria
  • Females suffering from other causes of infertility as tubal, uterine factors or known cases of endometriosis
  • severe cases of male factor as azospermia
  • females who were unable or not willing to participate in the study were excluded from the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group Itransvaginal Ultrasoundpoor responder females with age less than 35
Group IItransvaginal Ultrasoundpoor responder females with age more than 35
Primary Outcome Measures
NameTimeMethod
Number of MII oocytes2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr el aini hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath